Approvals/TGA/TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle

Approved

STANDARD

TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle

ViiV Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6cf762b9488f44fd
Product Name: TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle
Artg Id: 218644
Artg Name: TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle
Sponsor: ViiV Healthcare Pty Ltd
Company Detail Path: /organization/viiv-healthcare-pty-ltd
Artg Date: 2015-01-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1f820b2930b3151c3216a05c8b08c1c4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/49f7a157354b992fd3cb4d184f2c728b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 28, 2025

Approval ID

6cf762b9488f44fd

Type

Standard